BioSpace News Archive

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that it has signed a letter of intent (“LOI”) to partner with WorldCare Clinical, LLC for the Company’s rheumatoid arthritis (“RA”) diagnostic clinical imaging workflow. Per the agreement, WorldCare would serve as Navidea’s cen

Resverlogix Corp. announced its participation at the American College of Cardiology Scientific Sessions, together with the World Congress of Cardiology, presenting two virtual posters made available on demand via an eAbstracts System starting Saturday, March 28, 2020.

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced it had produced five COVID-19 vaccine candidates for testing in its preclinical models.

Axovant Gene Therapies Ltd., a clinical-stage company developing innovative gene therapies for neurological diseases, announced that management will participate in the virtual Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Day on Friday, April 3, 2020.

iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, announced that it has entered into a credit facility with Bridge Bank, a division of Western Alliance Bank, effective March 30, 2020.

Company to Host Conference Call with National Co-Principal Investigators Today at 4:15 p.m. ET to Provide Study Updates

On Saturday, March 21, General Motors, approached Esys Automation, a JR Automation company, to help produce face masks to combat the COVID-19 outbreak.

Thermo Scientific iCAP PRO Series ICP-OES instruments capture a complete spectrum in a single measurement for high matrix samples

Technology, social determinants of health, changing role of diabetes care and education specialists impact framework of diabetes self-management

Joining the global fight against the COVID-19 virus, GreyScan has officially launched development of the TVD-1, the world’s first fieldable trace virus detector.